Literature DB >> 9551881

Update: HIV counseling and testing using rapid tests--United States, 1995.

.   

Abstract

Approximately 25 million persons each year in the United States are tested for antibody to human immunodeficiency virus (HIV). Publicly funded counseling and testing (CT) programs conduct approximately 2.5 million of these tests each year. CT can have important prevention benefits; however, in 1995, 25% of persons testing HIV-positive and 33% of persons testing HIV-negative at publicly funded clinics did not return for their test results. Rapid tests to detect HIV antibody can be performed in an average of 10 minutes, enabling health-care providers to supply definitive negative and preliminary positive results to patients at the time of testing, potentially increasing the overall effectiveness of CT. In comparison, results from enzyme immunoassays (EIAs) currently used for HIV screening often are not available for 1-2 weeks. To quantify the potential advantages and disadvantages of using rapid tests for CT, CDC estimated the potential impact on the number of persons who would learn their HIV-test results. This report summarizes the results of the analysis and provides the basis for changing the Public Health Service (PHS) recommendations for providing HIV-test results.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9551881

Source DB:  PubMed          Journal:  MMWR Morb Mortal Wkly Rep        ISSN: 0149-2195            Impact factor:   17.586


  24 in total

1.  A simple saliva-based test for detecting antibodies to human immunodeficiency virus.

Authors:  W Schramm; G B Angulo; P C Torres; A Burgess-Cassler
Journal:  Clin Diagn Lab Immunol       Date:  1999-07

2.  Use of rapid and conventional testing technologies for human immunodeficiency virus type 1 serologic screening in a rural Kenyan reference laboratory.

Authors:  Ginamarie Foglia; G Donald Royster; K Monique Wasunna; Rukia Kibaya; Jennifer A Malia; Eva K Calero; Warren Sateren; Philip O Renzullo; Merlin L Robb; Deborah L Birx; Nelson L Michael
Journal:  J Clin Microbiol       Date:  2004-08       Impact factor: 5.948

3.  Use of stored serum from Uganda for development and evaluation of a human immunodeficiency virus type 1 testing algorithm involving multiple rapid immunoassays.

Authors:  Darrell E Singer; Noah Kiwanuka; David Serwadda; Fred Nalugoda; Linda Hird; Jamie Bulken-Hoover; Godfrey Kigozi; Jennifer A Malia; Eva K Calero; Warren Sateren; Merlin L Robb; Fred Wabwire-Mangen; Maria Wawer; Ronald H Gray; Nelson Sewankambo; Deborah L Birx; Nelson L Michael
Journal:  J Clin Microbiol       Date:  2005-10       Impact factor: 5.948

4.  Point-of-care testing for HIV: HIV counselling and testing.

Authors:  Bl Johnston; Jm Conly
Journal:  Can J Infect Dis       Date:  2002-03

Review 5.  Point-of-care testing in microbiology: the advantages and disadvantages of immunochromatographic test strips.

Authors:  Enno Stürenburg; Ralf Junker
Journal:  Dtsch Arztebl Int       Date:  2009-01-23       Impact factor: 5.594

6.  New tests for detecting HIV infection.

Authors:  T A Woehrle; B Branson
Journal:  West J Med       Date:  1998-12

Review 7.  Accuracy of Rapid Point-of-Care Diagnostic Tests for Hepatitis B Surface Antigen-A Systematic Review and Meta-analysis.

Authors:  Mehnaaz S Khuroo; Naira S Khuroo; Mohammad S Khuroo
Journal:  J Clin Exp Hepatol       Date:  2014-08-28

8.  Performance of the OraQuick rapid antibody test for diagnosis of human immunodeficiency virus type 1 infection in patients with various levels of exposure to highly active antiretroviral therapy.

Authors:  Robert J O'Connell; Teresa M Merritt; Jennifer A Malia; Thomas C VanCott; Matthew J Dolan; Hassan Zahwa; William P Bradley; Bernard M Branson; Nelson L Michael; Caroline C De Witt
Journal:  J Clin Microbiol       Date:  2003-05       Impact factor: 5.948

9.  Whole-blood agglutination assay for on-site detection of human immunodeficiency virus infection.

Authors:  Amita Gupta; Vijay K Chaudhary
Journal:  J Clin Microbiol       Date:  2003-07       Impact factor: 5.948

10.  Maternal adherence to the zidovudine regimen for HIV-exposed infants to prevent HIV infection: a preliminary study.

Authors:  Penelope A Demas; Mayris P Webber; Ellie E Schoenbaum; Jeremy Weedon; Janis McWayne; Elizabeth Enriquez; Mahrukh Bamji; Genevieve Lambert; Donald M Thea
Journal:  Pediatrics       Date:  2002-09       Impact factor: 7.124

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.